Related Experiment Video
Updated: Aug 11, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus
Basima A El-Akhras1, Roba M Talaat1, Samir A El-Masry1
1Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, 392053Sadat City University, Egypt.
Abstract:
microRNA-146a (miR-146a) plays an essential role in immune anomalies and organ injury of systemic lupus erythematosus (SLE) by regulating the disease's inflammation and complications. Here, we analyzed the expression of miR-146a in SLE and a panel of pro-inflammatory cytokines (IL-1, IL-6, IL-8, IL-17, and TNF-α). Association between all measured parameters and the disease's clinical manifestation and response to treatment was monitored. Our study populations were 113 SLE patients and 104 healthy volunteers. miR-146a expression in peripheral blood mononuclear cells (PBMCs) was measured by quantitative real-time PCR (RT-qPCR). The content of the plasma cytokines (IL-1β, IL-6, IL-8, IL-17, and TNF-α) was detected by enzyme-linked immunosorbent assay (ELISA). Compared with healthy controls, miR-146a expression was significantly increased (p < 0.05) in lupus patients. The analysis of the receiver operator characteristic curve (ROC) of miR-146a showed 91% sensitivity and 70% specificity. IL-1β, IL-6, and IL-17 cytokines were significantly increased (p < 0.001), while IL-8 and TNF-α were significantly decreased (p < 0.001) in SLE patients against controls. The expression of miR-146a and TNF-α was upregulated considerably in SLE patients with severe disease activity. miR-146a expression was positively correlated with IL-6. Our results pointed to the elevation of miR-146a as a trade marker of SLE patients. Reduction of IL-8 and TNF-α in combination with an elevation of IL-1β, IL-6, and IL-17 might refer to miR-146a's dual effect in controlling inflammation in lupus. Although we shed some light on the role of miR-146a in SLE, further study is recommended to improve our results.
Insights
microRNA-146a (miR-146a) is elevated in systemic lupus erythematosus (SLE) patients, acting as a potential biomarker. Its expression correlates with disease severity and specific cytokine profiles, suggesting a complex role in lupus inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by immune system dysregulation and organ damage.
- microRNA-146a (miR-146a) is implicated in immune responses and inflammation, making it a candidate for investigation in autoimmune conditions like SLE.
- Understanding the role of miR-146a and associated cytokines in SLE pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression levels of miR-146a in patients with SLE compared to healthy controls.
- To analyze the association between miR-146a expression, pro-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-17, TNF-α), and clinical manifestations in SLE.
- To evaluate the potential of miR-146a as a diagnostic or prognostic biomarker for SLE.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) was used to measure miR-146a expression in peripheral blood mononuclear cells (PBMCs) from 113 SLE patients and 104 healthy volunteers.
- Plasma levels of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-17, TNF-α) were quantified using enzyme-linked immunosorbent assay (ELISA).
- Statistical analyses, including ROC curve analysis, were performed to assess diagnostic accuracy and correlations between parameters and disease activity.
Main Results:
- miR-146a expression was significantly higher in SLE patients than in healthy controls (p < 0.05), with 91% sensitivity and 70% specificity.
- Significant differences in cytokine levels were observed: IL-1β, IL-6, and IL-17 were elevated (p < 0.001), while IL-8 and TNF-α were decreased (p < 0.001) in SLE patients.
- Upregulation of miR-146a and TNF-α was associated with severe SLE disease activity, and miR-146a expression positively correlated with IL-6 levels.
Conclusions:
- Elevated miR-146a serves as a potential biomarker for SLE.
- The observed cytokine profile (reduced IL-8/TNF-α, elevated IL-1β/IL-6/IL-17) suggests a dual role for miR-146a in modulating inflammation in SLE.
- Further research is warranted to elucidate the precise mechanisms of miR-146a and its therapeutic potential in SLE.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...